ImmVira announced to launch the construction of Global R&D and Commercialization Base
prnewswire.com
news
2022-10-18 08:22:00

SHENZHEN, China, Oct. 18, 2022 /PRNewswire/ -- On October 18, 2022, ImmVira launched the construction of its Global R&D and Commercialization Base in Suzhou Wuzhong Biomedical Industrial Park (Lifebay), China. The day before, ImmVira's "Shanghai Business and Clinical Center" officially opened on the Shanghai North Bund as well.
Global R&D and Commercialization Base, with a first-phase building area of nearly 30,000 square meters, is located in Wuzhong, Suzhou, and is expected to be completed and put into operation in mid-2024 as an integrated base with comprehensive functions, including manufacturing, R&D and office.
